Details for New Drug Application (NDA): 072321
✉ Email this page to a colleague
NDA 072321 describes PANCURONIUM BROMIDE, which is a drug marketed by Dr Reddys, Elkins Sinn, Hospira, and Igi Labs Inc, and is included in eleven NDAs. Additional details are available on the PANCURONIUM BROMIDE profile page.
The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.
The generic ingredient in PANCURONIUM BROMIDE is pancuronium bromide. There are six drug master file entries for this compound. Additional details are available on the pancuronium bromide profile page.
Summary for 072321
| Tradename: | PANCURONIUM BROMIDE |
| Applicant: | Hospira |
| Ingredient: | pancuronium bromide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072321
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2MG/ML | ||||
| Approval Date: | Jan 19, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
